preclinical – Page 17 – Science and Enterprise

Precision Cancer Therapy Start-Up Gains $110M in Early Funds

A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round.

Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism.

An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain.

An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways.

An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease.

GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.

Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks.

Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines.

A brain-computer interface device is shown to record the highest volume of brain signals from lab animals and sheep, according to its developers.

A new company is underway creating engineered antibodies to neutralize a range of coronaviruses, not just those causing Covid-19 infections.